Tafinlar 50 mg

Tafinlar 50 mg is a medicine authorised by Swissmedic under authorisation number 62781. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 January 2014 and the authorisation is valid without a time limit. ATC code L01EC02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 62781
  • ATC L01EC02
  • Synthetic medicines
Authorisation data
Authorisation number62781
NameTafinlar 50 mg
Full nameTafinlar 50 mg, Hartkapseln
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EC02
First authorisation13 January 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Tafinlar 50 mg, HartkapselnA13 January 2014
2Tafinlar 75 mg, HartkapselnA13 January 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Kapsel(n)L01EC0207.16.1.A
2120Kapsel(n)L01EC0207.16.1.A
328Kapsel(n)L01EC0207.16.1.A
4120Kapsel(n)L01EC0207.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tafinlar 50 mg authorised in Switzerland?

Yes. Tafinlar 50 mg is authorised by Swissmedic under authorisation number 62781, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Tafinlar 50 mg have?

Tafinlar 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Tafinlar 50 mg?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com